Survivor & Provider Activation for Colorectal Cancer Screening
(ASPIRES Trial)

Recruiting in Palo Alto (17 mi)

+3 other locations

Overseen byKaren Kim, MD, MS

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Chicago

No Placebo Group

Trial Summary

What is the purpose of this trial?The primary purpose of this study is to assess the best method for encouraging high-risk cancer survivors to get screened for colorectal cancer at the recommended age.

Eligibility Criteria

This trial is for high-risk cancer survivors without a family history of colorectal cancer, who were treated with certain types of radiation, and haven't had recent colorectal screenings. Participants must have a smartphone, be part of the Childhood Cancer Survivor Study, speak English, and live in the U.S.

Inclusion Criteria

Enrolled on the Childhood Cancer Survivor Study

My family has no history of colorectal cancer.

I have received radiation therapy to my abdomen, pelvis, spine, or whole body.

+3 more

Exclusion Criteria

Do not reside in the United States

I do not speak English.

Participant Groups

The ASPIRES study is testing different methods to motivate these survivors to undergo colorectal cancer screening. It compares no intervention (control) with strategies aimed at activating patients directly or through their primary care providers.

3Treatment groups

Experimental Treatment

Group I: Group1: Control (C)Experimental Treatment1 Intervention

Electronic educational materials (C).

Group II: Group 3: Patient Activation and PCP Activation (PA + PCP)Experimental Treatment3 Interventions

C + PA + PCP activation (PA+PCP) with physician materials about colorectal cancer risk in this population

Group III: Group 2: Patient Activation (PA)Experimental Treatment2 Interventions

C + patient activation (PA) consisting of interactive tailored text messages with links to videos and resources